Page last updated: 2024-10-25

deferoxamine and Diffuse Tenosynovial Giant Cell Tumor

deferoxamine has been researched along with Diffuse Tenosynovial Giant Cell Tumor in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buettner, GR1
Chamulitrat, W1

Other Studies

1 other study available for deferoxamine and Diffuse Tenosynovial Giant Cell Tumor

ArticleYear
The catalytic activity of iron in synovial fluid as monitored by the ascorbate free radical.
    Free radical biology & medicine, 1990, Volume: 8, Issue:1

    Topics: Ascorbic Acid; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Iron; Oxid

1990